FDA Inspection
Resilience US, Inc.Resilience US, Inc. – FDA Inspection, Dec 23, 2009
Record Details
This FDA Inspection record concerns Resilience US, Inc., with an inspection on December 23, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Resilience US, Inc.
- Inspection Date
- December 23, 2009
- Product Type
- Drugs
View Company Profile
ID · dd7af575-1f4b-49e6-8ef7-ea95f944fde3
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 636149
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Resilience US, Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| January 21, 2025 | VAI | Cincinnati District Office | Drug Quality Assurance |
| August 9, 2019 | VAI | Center for Devices and Radiological Health | New Drug Evaluation |
| March 8, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 7, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 27, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Resilience US, Inc.
- FDA Inspection 1258820 - 2025-01-21
- FDA Inspection 1099149 - 2019-08-09
- FDA Inspection 1043914 - 2018-03-08
- FDA Inspection 1028106 - 2017-09-07
- FDA Inspection 1018002 - 2017-06-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.